kabutan

KNC Laboratories Co., Ltd.(6568) Summary

6568
TSE Growth
KNC Laboratories Co., Ltd.
1,225
JPY
-10
(-0.81%)
Jan 29, 3:23 pm JST
8.00
USD
Jan 29, 1:23 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
16.2
PBR
0.71
Yield
2.69%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,235 JPY 8.06 USD
Previous Close Jan 28
1,235 JPY 8.09 USD
High Jan 29, 9:13 am
1,236 JPY 8.07 USD
Low Jan 29, 2:29 pm
1,220 JPY 7.97 USD
Volume
7,700
Trading Value
9.00M JPY 0.06M USD
VWAP
1225.21 JPY 8.01 USD
Minimum Trading Value
122,500 JPY 800 USD
Market Cap
9.53B JPY 0.06B USD
Number of Trades
28
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly Low
1-Year Average
27
1-Year High Jan 21, 2026
505
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 114,700
Jan 16, 2026 0 93,800
Jan 9, 2026 0 93,100
Dec 26, 2025 0 88,200
Dec 19, 2025 0 85,400
Company Profile
KNC Laboratories Co., Ltd. specializes in contract research, development, and scale-up production of organic compounds, offering proprietary technologies in pharmaceuticals, functional materials, and biotechnology.
Sector
Services
KNC Laboratories Co., Ltd. primarily engages in research, development, and production solutions for organic chemicals. The company supplies samples and products necessary for customers' product development and sales, providing problem-solving services tailored to various development stages. Their main focus is on functional chemicals and intermediates used in pharmaceutical and information electronics fields. KNC offers comprehensive solutions from research to mass production stages, adapting services to meet customers' product development needs. Through its functional materials, pharmaceutical, and biotechnology divisions, the company handles display materials, semiconductor manufacturing chemicals, pharmaceutical active ingredients, raw materials for clinical trials, and additives for antibody drug manufacturing. By working closely with customers, KNC supports the improvement of product development efficiency and reduction of development timelines.